HPV‐mediated cervical carcinogenesis: concepts and clinical implications

Journal of Pathology - Tập 208 Số 2 - Trang 152-164 - 2006
Peter J.F. Snijders1, Renske D.M. Steenbergen2, Daniëlle A.M. Heideman3, Chris J.L.M. Meijer2
1Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands
2Department of Pathology, VU University Medical Center, de Boelelaan 1117, 1081, HV, Amsterdam, The Netherlands
3Pathology

Tóm tắt

Abstract

Persistent infection with a high‐risk human papillomavirus (hrHPV) is generally accepted as a necessary cause of cervical cancer. However, cervical cancer is a rare complication of an hrHPV infection since most such infections are transient, not even giving rise to cervical lesions. On average, it takes 12–15 years before a persistent hrHPV infection may ultimately, via consecutive premalignant stages (ie CIN lesions), lead to an overt cervical carcinoma. This argues that HPV‐induced cervical carcinogenesis is multi‐step in nature. In this review, the data from hrHPV‐mediated in vitro transformation studies and those obtained from analysis of clinical specimens have been merged into a cervical cancer progression model. According to this model, a crucial decision maker in the early stages following infection involves individual susceptibility for certain HPV types depending on the genetic make‐up of immune surveillance determinants. Once a CIN lesion has developed, altered transcriptional regulation of the viral E6/E7 oncogenes, resulting in genomic instability and distinguishing the process of cell transformation from a productive viral infection, probably provides the subsequent important step towards malignancy. The additional (epi)genetic alterations that subsequently accumulate in high‐grade CIN lesions may result in overt malignancy via immortality and growth conditions that gradually become less sensitive to growth‐modulating influences mediated by cytokines and cell–cell and cell–matrix adhesions. The potential implications of hrHPV testing and some other biomarkers deduced from this model for cervical screening and the clinical management of CIN disease are also discussed. Copyright © 2006 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Từ khóa


Tài liệu tham khảo

10.1093/oxfordjournals.jncimonographs.a003479

10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F

10.1038/nrc798

10.1056/NEJMoa021641

10.1016/S0168-1702(02)00190-9

10.1126/science.2537532

10.1128/jvi.67.5.2521-2528.1993

10.1038/sj.onc.1202953

10.1128/JVI.78.21.11451-11460.2004

10.1002/(SICI)1097-0142(19990501)85:9<2011::AID-CNCR19>3.0.CO;2-N

10.1002/path.1480

10.1016/j.jcv.2004.12.008

Meijer CJ, 2000, Screening for cervical cancer: should we test for infection with high‐risk HPV?, CMAJ, 163, 535

10.1084/jem.20042158

10.1002/ijc.90010

10.1002/ijc.21204

10.1002/path.1433

10.1056/NEJM199911253412201

10.1054/bjoc.2001.1926

10.1158/1078-0432.CCR-04-2599

10.1016/S0140-6736(01)06809-X

10.1086/427557

10.1001/jama.1992.03480180079033

10.1016/0046-8177(92)90232-R

10.1016/0042-6822(92)90688-L

10.1159/000150373

10.1101/gad.9.19.2335

10.1128/JVI.78.8.4063-4073.2004

10.1128/JVI.73.6.5026-5033.1999

Klaes R, 1999, Detection of high‐risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes, Cancer Res, 59, 6132

10.1158/1078-0432.CCR-03-0565

10.1073/pnas.92.5.1654

10.1002/ijc.11691

10.1158/0008-5472.CAN-03-3214

Dürst M, 1987, Molecular and cytogenetic analysis of immortalized human primary keratinocytes obtained after transfection with human papillomavirus type 16 DNA, Oncogene, 1, 251

10.1128/JVI.61.4.1061-1066.1987

10.1128/JVI.63.10.4417-4421.1989

10.1002/j.1460-2075.1989.tb08570.x

Chen TM, 1993, Genetic analysis of in vitro progression of human papillomavirus‐transfected human cervical cells, Cancer Res, 53, 1167

Seagon S, 1994, Genetic analysis of an in vitro model system for human papillomavirus type 16‐associated tumorigenesis, Cancer Res, 54, 5593

Steenbergen RD, 1996, Transition of human papillomavirus type 16 and 18 transfected human foreskin keratinocytes towards immortality: activation of telomerase and allele losses at 3p, 10p, 11q and/or 18q, Oncogene, 13, 1249

10.1128/JVI.77.2.1551-1563.2003

10.1002/(SICI)1097-0215(19980504)76:3<412::AID-IJC20>3.0.CO;2-B

10.1128/JVI.72.1.749-757.1998

10.1016/j.jcv.2004.11.019

10.1158/0008-5472.CAN-03-3739

10.1128/MCB.14.2.961

10.1126/science.7605428

10.1016/S0092-8674(00)80538-3

10.1093/jnci/93.11.865

10.1038/380079a0

10.1006/viro.2002.1542

10.1002/gcc.1134

10.1002/gcc.20192

Poignee M, 2001, Evidence for a putative senescence gene locus within the chromosomal region 10p14–p15, Cancer Res, 61, 7118

10.1002/gcc.2870140206

Snijders PJ, 1998, Telomerase activity exclusively in cervical carcinomas and a subset of cervical intraepithelial neoplasia grade III lesions: strong association with elevated messenger RNA levels of its catalytic subunit and high‐risk human papillomavirus DNA, Cancer Res, 58, 3812

10.1002/ijc.11145

10.1016/S0002-9440(10)61143-1

10.1002/mc.2940020103

10.1073/pnas.91.15.6953

10.1093/jnci/djh031

10.1038/86934

10.1074/jbc.M305387200

10.1182/blood-2005-02-0817

10.1038/sj.onc.1202765

10.1002/(SICI)1097-0215(20000615)86:6<811::AID-IJC9>3.0.CO;2-J

10.1038/sj.onc.1203643

10.1074/jbc.M409915200

10.1159/000291854

Lathion S, 2003, Notch1 can contribute to viral‐induced transformation of primary human keratinocytes, Cancer Res, 63, 8687

10.1016/j.yexcr.2005.01.015

10.1038/bjc.1993.254

10.1084/jem.179.1.335

10.1002/(SICI)1098-2264(199912)26:4<346::AID-GCC9>3.0.CO;2-D

Chatterjee A, 2001, Mapping the sites of putative tumor suppressor genes at 6p25 and 6p21.3 in cervical carcinoma: occurrence of allelic deletions in precancerous lesions, Cancer Res, 61, 2119

10.1002/gcc.20048

10.5858/2003-127-959-HPDTAA

10.1038/sj.bjc.6600918

10.1002/path.981

10.1002/ijc.20958

10.1093/jnci/93.4.293

Berkhof J, Evaluation of cervical screening strategies with adjunct high‐risk human papillomavirus testing for women with borderline or mild dyskaryosis, Int J Cancer

10.1002/1097-0142(20010225)93:1<8::AID-CNCR9001>3.0.CO;2-K

10.1002/1097-0339(200008)23:2<127::AID-DC13>3.0.CO;2-I

10.1002/(SICI)1097-0215(19980209)75:4<536::AID-IJC8>3.0.CO;2-U

10.1002/ijc.20678

10.1002/path.1480

10.1111/j.1365-2303.2004.00227.x

10.1136/bmj.322.7291.893

10.1016/S0140-6736(03)14955-0

10.1002/ijc.20076

10.1054/bjoc.2000.1689

10.1016/S0090-8258(03)00415-3

10.1097/00006254-200407000-00024

10.1038/bjc.1996.196

10.1016/S0029-7844(99)00289-6

van BallegooijenM ReboljM MeerdingWJ van den Akker‐van MarleME BerkersLM HabbemaJD.De praktijk van het bevolkingsonderzoek naar baarmoederhalskanker in Nederland in 2001. Department of Public Health Erasmus Medical Center: Rotterdam 2003.

10.1136/jcp.55.6.435

10.1016/S0140-6736(99)04110-0

10.1002/(SICI)1097-0215(19961211)68:6<766::AID-IJC13>3.0.CO;2-Z

10.1002/ijc.20244

10.1093/jnci/dji014

10.1038/sj.bjc.6600688

10.1002/ijc.21210

10.1093/jnci/dji187

10.1093/jnci/dji186

10.1016/j.jviromet.2004.11.005

10.1002/jmv.20062

10.1158/1055-9965.EPI-04-0410

10.1002/ijc.20839

10.1002/ijc.1174

10.1002/ijc.11589

Klaes R, 1999, Detection of high‐risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes, Cancer Res, 59, 6132

10.1159/000059710

10.1136/jcp.56.1.31

10.1136/jcp.2003.013730

van den Brule AJ, 1991, Nonradioactive RNA in situ hybridization detection of human papillomavirus 16‐E7 transcripts in squamous cell carcinomas of the uterine cervix using confocal laser scan microscopy, Am J Pathol, 139, 1037